Post Allogeneic Stem Cell Transplant Outcomes Following Response to Hypomethylating Agent Therapy in Myelodysplastic Syndromes Are Predicted By Persistent International Prognostic Scoring System-Molecular Risk

被引:0
|
作者
Frumm, Stacey M. [1 ]
Kim, Haesook T. [2 ]
Kelkar, Amar H. [3 ]
Ho, Vincent T. [4 ]
Gooptu, Mahasweta [3 ]
Gibson, Christopher James [3 ]
Koreth, John [3 ]
Shapiro, Roman M. [3 ]
Romee, Rizwan [3 ]
Nikiforow, Sarah [3 ]
Antin, Joseph H. [5 ]
Soiffer, Robert J. [3 ]
Rolles, Benjamin [6 ]
Shimony, Shai [7 ]
Bewersdorf, Jan Philipp [8 ]
Kewan, Tariq [9 ]
Alhajahjeh, Abdulrahman [10 ]
Luskin, Marlise R. [4 ]
Garcia, Jacqueline S. [7 ]
Chen, Evan C. [3 ]
Lane, Andrew A. [11 ]
Wadleigh, Martha [3 ]
Winer, Eric S. [3 ]
Stone, Richard M. [3 ]
DeAngelo, Daniel J. [3 ]
Zeidan, Amer M. [12 ]
Lindsley, Coleman [3 ]
Cutler, Corey [3 ]
Stahl, Maximilian [4 ]
机构
[1] Brigham & Womens Hosp, Brookline, MA USA
[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[5] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA USA
[6] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA USA
[7] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Yale Univ, Dept Internal Med, Sect Hematol, New Haven, CT USA
[10] Univ Jordan, Amman, Jordan
[11] Dana Farber Canc Inst Inc, Dept Med Oncol, Boston, MA USA
[12] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol,Yale Canc Ctr, New Haven, CT USA
关键词
D O I
10.1182/blood-2023-185220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
    Lee, Yoo Jin
    Park, Sung Woo
    Lee, In Hee
    Ahn, Jae Sook
    Kim, Hyeoung Joon
    Chung, Joo Seop
    Shin, Ho Jin
    Lee, Won Sik
    Lee, Sang Min
    Joo, Young Don
    Kim, Hawk
    Lee, Ho Sup
    Kim, Yang Soo
    Cho, Yoon Young
    Moon, Joon Ho
    Sohn, Sang Kyun
    ANNALS OF HEMATOLOGY, 2016, 95 (11) : 1795 - 1804
  • [2] Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
    Yoo Jin Lee
    Sung Woo Park
    In Hee Lee
    Jae Sook Ahn
    Hyeoung Joon Kim
    Joo Seop Chung
    Ho Jin Shin
    Won Sik Lee
    Sang Min Lee
    Young Don Joo
    Hawk Kim
    Ho Sup Lee
    Yang Soo Kim
    Yoon Young Cho
    Joon Ho Moon
    Sang Kyun Sohn
    Annals of Hematology, 2016, 95 : 1795 - 1804
  • [3] Performance of the Molecular International Prognostic Scoring System (IPSS-M) in Hypomethylating Agent-Treated Patients with Myelodysplastic Syndromes
    Chien, Kelly S.
    Urrutia, Samuel
    Li, Ziyi
    Kanagal-Shamanna, Rashmi
    Abdelhakeem, Ahmed
    Abuasab, Tareq
    Almanza, Emmanuel
    Gener-Ricos, Georgina
    Bataller, Alex
    Bazinet, Alexandre
    Montalban-Bravo, Guillermo
    Short, Nicholas J.
    Jabbour, Elias
    Kadia, Tapan M.
    Ravandi, Farhad
    Borthakur, Gautam
    Hammond, Danielle E.
    Swaminathan, Mahesh
    Sasaki, Koji
    Dong, Xiao Qin
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    BLOOD, 2023, 142
  • [4] Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate into Better Post-Transplant Outcomes for Patients with Myelodysplastic Syndromes
    Alzahrani, Musa
    Power, Maryse M.
    Nevill, Emilie
    Abou Mourad, Yasser
    Barnett, Michael J.
    Broady, Raewyn
    Forrest, Donna L.
    Gerrie, Alina S.
    Hogge, Donna E.
    Nantel, Stephen H.
    Sanford, David
    Sutherland, Heather J.
    Toze, Cynthia L.
    Song, Kevin W.
    Song, Kevin W.
    Nevill, Thomas J.
    Narayanan, Sujaatha
    BLOOD, 2016, 128 (22)
  • [5] Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms
    Yang, Tingting
    Jiang, Binqian
    Luo, Yi
    Zhao, Yanmin
    Ouyang, Guifang
    Yu, Jian
    Lan, Jianping
    Lu, Ying
    Lai, Xiaoyu
    Ye, Baodong
    Chen, Yi
    Liu, Lizhen
    Xu, Yang
    Shi, Pengfei
    Xiao, Haowen
    Hu, Huixian
    Guo, Qunyi
    Fu, Huarui
    Ye, Yishan
    Wang, Xinyu
    Sun, Jie
    Zheng, Weiyan
    He, Jingsong
    Zhao, Yi
    Wu, Wenjun
    Cai, Zhen
    Wei, Guoqing
    Huang, He
    Shi, Jimin
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : E391 - E394
  • [6] Prognostic mutations identified by whole-exome sequencing and validation of the Molecular International Prognostic Scoring System in myelodysplastic syndromes after allogeneic haematopoietic stem cell transplantation
    Wang, Hong
    Li, Xueqian
    Qi, Jiaqian
    Liu, Hong
    Chu, Tiantian
    Xu, Xiaoyan
    Qiu, Huiying
    Fu, Chengcheng
    Tang, Xiaowen
    Ruan, Changgeng
    Wu, Depei
    Han, Yue
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 1899 - 1909
  • [7] Relapse Prediction Post Allogeneic Hematopoietic Cell Transplant for Myelodysplastic Syndromes Is Not Improved with Use of the More Stringent Blast Percentage Categories in the Revised International Prognostic Scoring System
    Shune, Leyla
    Sachs, Zohar
    Defor, Todd E.
    Dolan, Michelle
    Weisdorf, Daniel J.
    Ustun, Celalettin
    Warlick, Erica D.
    BLOOD, 2012, 120 (21)
  • [8] REPORT ON OUTCOME OF HYPOMETHYLATING THERAPY WITH ANALYSIS ON PROGNOSTIC VALUE OF REVISED-INTERNATIONAL PROGNOSTIC SCORING SYSTEM IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES OF LOWER-RISK BASED ON IPSS
    Lee, Y.
    Moon, J.
    Yoon, J.
    Kim, J.
    Sohn, S.
    HAEMATOLOGICA, 2016, 101 : 507 - 507
  • [9] Validation of the Molecular International Prognostic Scoring System (IPSS-M) Risk Stratification Model for Myelodysplastic Syndromes
    Aguirre, Luis E.
    Al Ali, Najla
    Ball, Somedeb
    Singh, Avani M.
    Jain, Akriti G.
    Chan, Onyee
    Schwabkey, Zaker, I
    Tinsley-Vance, Sara M.
    Kuykendall, Andrew
    Sweet, Kendra
    Lancet, Jeffrey E.
    Padron, Eric
    Sallman, David A.
    Komrokji, Rami S.
    BLOOD, 2022, 140 : 1125 - 1127
  • [10] Transplant-specific EBMT scoring system improves prognostic capability in myelodysplastic syndromes after allogeneic stem-stell transplantation
    Gagelmann, Nico
    Eikema, Diderik-Jan
    Beelen, Dietrich
    Stelljes, Matthias
    Koster, Linda
    Mufti, Ghulam
    Niederwieser, Dietger
    Ehninger, Gerhard
    Sengeloev, Henrik
    Nagler, Arnon
    Yakoub-Agha, Ibrahim
    Meijer, Ellen
    Ljungman, Per
    Maertens, Johan
    Kanz, Lothar
    Corral, Lucia L.
    Brecht, Arne
    Craddock, Charles
    Finke, Juergen
    Cornelissen, Jan J.
    Bernasconi, Paolo
    Chevallier, Patrice
    Sierra, Jorge
    Robin, Marie
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2018, 53 : 117 - 118